UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in ChampionX Co. (NASDAQ:CHX - Free Report) by 17.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 411,555 shares of the company's stock after selling 86,016 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.22% of ChampionX worth $11,190,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of CHX. Barclays PLC boosted its stake in ChampionX by 147.2% in the third quarter. Barclays PLC now owns 357,081 shares of the company's stock worth $10,766,000 after purchasing an additional 212,654 shares in the last quarter. KBC Group NV lifted its position in ChampionX by 42.3% during the 4th quarter. KBC Group NV now owns 8,289 shares of the company's stock worth $225,000 after buying an additional 2,462 shares in the last quarter. Pacer Advisors Inc. grew its holdings in ChampionX by 1.9% during the 4th quarter. Pacer Advisors Inc. now owns 28,394 shares of the company's stock worth $772,000 after acquiring an additional 532 shares during the last quarter. R Squared Ltd acquired a new stake in ChampionX in the 4th quarter valued at about $103,000. Finally, Calamos Advisors LLC raised its stake in shares of ChampionX by 470.4% in the fourth quarter. Calamos Advisors LLC now owns 1,494,500 shares of the company's stock worth $40,635,000 after acquiring an additional 1,232,500 shares during the last quarter. 98.99% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Separately, Stifel Nicolaus increased their price target on shares of ChampionX from $39.00 to $40.00 and gave the company a "buy" rating in a research note on Monday, May 5th.
View Our Latest Report on CHX
ChampionX Trading Up 3.0%
Shares of CHX stock traded up $0.72 on Tuesday, reaching $24.98. 2,718,033 shares of the stock were exchanged, compared to its average volume of 2,742,244. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.99 and a quick ratio of 1.36. ChampionX Co. has a one year low of $21.92 and a one year high of $35.94. The stock has a market cap of $4.78 billion, a PE ratio of 15.14 and a beta of 1.52. The stock has a 50 day moving average price of $25.32 and a 200 day moving average price of $27.75.
ChampionX (NASDAQ:CHX - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.41 by $0.09. ChampionX had a return on equity of 19.84% and a net margin of 8.81%. The firm had revenue of $864.46 million during the quarter, compared to analyst estimates of $900.59 million. During the same period last year, the company earned $0.50 earnings per share. The company's revenue was down 6.3% on a year-over-year basis. Equities research analysts forecast that ChampionX Co. will post 1.92 EPS for the current fiscal year.
ChampionX Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Thursday, July 3rd will be issued a dividend of $0.095 per share. This represents a $0.38 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date is Thursday, July 3rd. ChampionX's dividend payout ratio is presently 25.17%.
ChampionX Company Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Read More

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.